Demographic and clinical characteristics of patients with new-onset HIV/CHC coinfection with the known HCV genotype


DOI: https://dx.doi.org/10.18565/epidem.2022.12.1.53-9

Volkova S.B., Podymova A.S.

Sverdlovsk Regional Center for AIDS Prevention and Control, Yekaterinburg, Russia
Objective. To study the demographic and clinical characteristics of patients with HIV/CHC co-infection with the known hepatitis C virus (HCV) genotype.
Subjects and methods. The investigators analyzed data on 700 patients with HIV/CHC co-infection with available information on genotyping, who were first identified and registered in the Sverdlovsk Regional Center for AIDS Prevention and Control for HIV infection in the period from 2016 to 2019.
Results. HCV genotype 1 was most common (50% of cases), genotype 3 was found in 45% of cases. The proportion of patients with F3–F4 fibrosis was 15%. In this cohort, the narcotic way of getting HIV prevailed (58%) versus 37% through heterosexual contacts. At least one comorbidity was present in 99% of patients. There were also deviations from the normal laboratory parameters (ALT, AST, creatinine, etc.).
Conclusion. The clinical characteristics of patients with HIV/HCV coinfection differ from those of patients with HCV monoinfection; and these differences may influence the timing of initiation and choice of antiviral therapy for CHC. It is preferable to use direct-acting antiviral drugs in co-infected patients.

Literature


1. Справка Федерального научно-методического центра по профилактике и борьбе со СПИД. ВИЧ-инфекция в Российской Федерации на 30 июня 2020 г. http://www.hivrussia.info/wp-content/uploads/2020/07/Spravka-VICH-v-Rossii-1-polugodie-2020.pdf

[Reference Data from the Federal Scientific and Methodological Center for the Prevention and Control of AIDS. HIV infection in the Russian Federation as of June 30, 2020. (In Russ.). http://www.hivrussia.info/wp-content/uploads /2020/07/Spravka-VICH-v-Rossii-1-polugodie-2020.pdf


2. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2015 году». М,, 2016: 200. https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ ID=6851

[State report «On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2015»]. Moscow, 2016: 200. (In Russ.) https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=6851


3. Государственный доклад «О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2019 году». М., 2020: 299. https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ ID=14933

[State report «On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019»]. Moscow, 2020: 299. (In Russ.). https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933


4. ВОЗ. Гепатит С. https://www.who.int/ru/news-room/fact-sheets/detail/ hepatitis-c

[WHO. Hepatitis C]. https://www.who.int/ru/news-room/fact-sheets/detail /hepatitis-c


5. Gardenier D., Olson M.C. Hepatitis C in 2019: Are We There Yet? J. Nurse Pract. Elsevier 2019; 15(6): 415–19el. DOI: 10.1016/j.nurpra.2018.12.009


6. Пименов Н.Н., Чуланов В.П., Комарова С.В., Карандашова И.В., Неверов А.Д., Михайловская Г.В. и др. Гепатит С в России: эпидемиологическая характеристика и пути совершенствования диагностики и надзора. Эпидемиол. и инфекц. бол. 2012; 17(3): 4–10. DOI: https://doi.org/10.17816/EID40623

Pimenov N.N., Chulanov V.P., Komarova S.V., Karandashova I.V., Neverov A.D., Mikhailovskaya G.V. et al. [Hepatitis C in Russia: current epidemiology and approaches to improving diagnosis and surveillance]. Epidemiology and Infectious Diseases 2012; 17(3): 4–10. (In Russ.). DOI: https://doi.org/ 10.17816/ EID40623


7. World Health Organization, HIV and hepatitis coinfections. WHO, 2017. https://www.who.int/hiv/topics/hepatitis/en/


8. Пименов Н.Н., Вдовин А.В., Комарова С.В., Мамонова, Н.А., Чуланов В.П., Покровский В.И. Актуальность и перспективы внедрения в России Единого федерального регистра больных вирусными гепатитами В и С. Тер. архив 2013; 85(11): 4–9.

Pimenov N.N., Vdovin A.V., Komarova S.V., Mamonova, N.A., Chulanov V.P., Pokrovskii V.I. [The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia]. Therapeutic archive 2013; 85(11): 4–9. (In Russ.).


9. Viral Hepatitis. Published by the Viral Hepatitis Prevention Board (VHPB) 2011; 19(1). http://www.vhpb.org/files/html/Meetings_and_publications/ Viral_ Hepatitis_Newsletters/vhv19n1.pdf


10. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin. Microbiol. Infect. 2011; 17(2): 107–15. DOI: 10.1111/j.1469-0691.2010.03432.x


11. Яшина Т.Л., Фаворов М.О., Шахгильдян И.В., Ярашева Д.М., Назарова О.И., Деревянко Е.Н., Оммадова М.И., Онищенко Г.Г. Распространение маркеров гепатита C среди населения некоторых регионов России и Средней Азии. Журнал микробиологии, эпидемиологии и иммунобиологии 1993; (5): 46–9.

Iashina T., Favorov M.O., Shakhgildyan I.V., Yarasheva D.M., Nazarova O.I., Derevyanko E.N., Ommadova M.I., Onishchenko G.G. [The spread of hepatitis C markers among the population of regions of Russia and Central Asia]. Journal of microbiology, epidemiology and immunology 1993; (5): 46–9. (In Russ.).


12. Национальное научное общество инфекционистов. Хронический вирусный гепатит С (ХВГС) у взрослых. Клинические рекомендации. М, 2018. 90 с. https://nnoi.ru/uploads/files/kr_hvgs.pdf

[National Scientific Society of Infectious Diseases. Chronic viral hepatitis C (CVHC) in adults. Clinical guidelines]. Moscow, 2018. 90 p. (In Russ.). https://nnoi.ru/uploads/files/kr_hvgs.pdf


13. Kattakuzhy S., Levy R., Rosenthal E., Tang L., Wilson E., Kottilil S. Hepatitis C genotype 3 disease. Hepatology International. Springer India, 2016; 10(6): 861–70. DOI: 10.1007/s12072-016-9748-z


14. Еuropean Association for the Study of the Liver. EASL Recommendations on Treatment of Hepatitis C 2018. J. Hepatol. 2018; 69(2): 461–511. DOI: 10.1016/j.jhep.2018.03.0


15. Максимов С.Л. Универсальная безинтерфероновая схема терапии хронического гепатита С у больных ВИЧ-инфекцией. Инфекционные болезни: Новости. Мнения. Обучение 2016; (4): 118–30.

Maksimov S.L. [Universal interferon-free regimen for the treatment of chronic hepatitis C in patients with HIV infection]. Infectious Diseases: News. Opinions. Training 2016; (4): 118–30. (In Russ.)


16. Shiffman M.L., Stewart C.A., Hofmann C.M., Contos M.J., Luketic V.A., Sterling R.K., Sanyal A.J. Chronic Infection with Hepatitis C Virus in Patients with Elevated or Persistently Normal Serum Alanine Aminotransferase Levels: Comparison of Hepatic Histology and Response to Interferon Therapy. J. Infect. Dis. 2000; 182(6): 1595–1601. DOI: 10.1086/317612


17. Рассохин В.В., Боева Е.В. Вопросы эпидемиологии и патогенеза сочетанной инфекции ВГС и ВИЧ. ВИЧ-инфекция и иммуносупрессии 2020; 12(1): 32–46. DOI: 10.22328/2077-9828-2020-12-1-32-46

Rassokhin V.V., Boeva E.V. [Issues of epidemiology and pathogenesis of HIV-HCV co-infection]. HIV Infection and Immunosuppressive Disorders 2020; 12(1): 32–46. DOI: 10.22328/2077-9828-2020-12-1-32-46


18. Базыкина Е.А., Туркутюков В.Б., Троценко О.Е., Котова В.О., Бутакова Л.В., Балахонцева Л.А. Молекулярно-генетические особенности вируса гепатита С у ВИЧ-позитивных пациентов Дальнего Востока России, в том числе коинфицированных вирусом гепатита В. ВИЧ-инфекция и иммуносупрессии 2020; 12(1): 58–67. DOI: 10.22328/2077-9828-2020-12-1-58-67

Bazykina E.A., Turkutyukov V.B., Trotsenko O.E., Kotova V.O., Butakova L.V., Balakhontseva L.A. [Molecular-genetic peculiarities of hepatitis C virus in patients with HIV-infection residing in the russian far east]. HIV Infection and Immunosuppressive Disorders 2020; 12(1): 58–67. DOI: 10.22328/2077-9828-2020-12-1-58-67


19. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol. 2020; 73(5): 1170–218. DOI: 10.1016/j.jhep.2020.08.018


20. Покровский В.В. ВИЧ-инфекция и СПИД. Клинические рекомендации. М.: ГЭОТАР-Медиа, 2019. 160 с.

Pokrovsky V.V. [HIV infection and AIDS. Сlinical guidelines]. Moscow: GEOTAR-Media, 2019. 160 p. (In Russ.).


About the Autors


Svetlana B. Volkova, Infectiologist, Head, Clinical and Diagnostic Department Three, Sverdlovsk Regional Center for AIDS Prevention and Control, Ekaterinburg, Russia; svetlana@olvo.ru; https://orcid.org/0000-0002-8516-018X
Anzhelika S. Podymova, MD, Head Physician, Sverdlovsk Regional Center for AIDS Prevention and Control, Ekaterinburg, Russia; glvrach@livehiv.ru; https://orcid.org/0000-0001-7345-0801


Similar Articles


Бионика Медиа